Text-Messaging, Online Peer Support Group, and Coaching Strategies to Optimize the HIV Prevention Continuum for Youth: Protocol for a Randomized Controlled Trial.

HIV/AIDS MSM adolescents homelessness mHealth prevention transgender

Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
09 08 2019
Historique:
received: 29 05 2018
accepted: 05 02 2019
revised: 31 01 2019
entrez: 11 8 2019
pubmed: 11 8 2019
medline: 11 8 2019
Statut: epublish

Résumé

America's increasing HIV epidemic among youth suggests the need to identify novel strategies to leverage services and settings where youth at high risk (YAHR) for HIV can be engaged in prevention. Scalable, efficacious, and cost-effective strategies are needed, which support youth during developmental transitions when risks arise. Evidence-based behavioral interventions (EBIs) have typically relied on time-limited, scripted, and manualized protocols that were often delivered with low fidelity and lacked evidence for effectiveness. This study aims to examine efficacy, implementation, and cost-effectiveness of easily mountable and adaptable, technology-based behavioral interventions in the context of an enhanced standard of care and study assessments that implement the guidelines of Centers for Disease Control and Prevention (CDC) for routine, repeat HIV, and sexually transmitted infection (STI) testing for high-risk youth. Youth aged between 12 and 24 years (n=1500) are being recruited from community-based organizations and clinics serving gay, bisexual, and transgender youth, homeless youth, and postincarcerated youth, with eligibility algorithms weighting African American and Latino youth to reflect disparities in HIV incidence. At baseline and 4-month intervals over 24 months (12 months for lower-risk youth), interviewers monitor uptake of HIV prevention continuum steps (linkage to health care, use of pre- or postexposure prophylaxis, condoms, and prevention services) and secondary outcomes of substance use, mental health, and housing security. Assessments include rapid diagnostic tests for HIV, STIs, drugs, and alcohol. The study is powered to detect modest intervention effects among gay or bisexual male and transgender youth with 70% retention. Youth are randomized to 4 conditions: (1) enhanced standard of care of automated text-messaging and monitoring (AMM) and repeat HIV/STI testing assessment procedures (n=690); (2) online group peer support via private social media plus AMM (n=270); (3) coaching that is strengths-based, youth-centered, unscripted, based on common practice elements of EBI, available over 24 months, and delivered by near-peer paraprofessionals via text, phone, and in-person, plus AMM (n=270); and (4) online group peer support plus coaching and AMM (n=270). The project was funded in September 2016 and enrollment began in May 2017. Enrollment will be completed between June and August 2019. Data analysis is currently underway, and the first results are expected to be submitted for publication in 2019. This hybrid implementation-effectiveness study examines alternative models for implementing the CDC guidelines for routine HIV/STI testing for YAHR of acquiring HIV and for delivering evidence-based behavioral intervention content in modular elements instead of scripted manuals and available over 24 months of follow-up, while also monitoring implementation, costs, and effectiveness. The greatest impacts are expected for coaching, whereas online group peer support is expected to have lower impact but may be more cost-effective. ClinicalTrials.gov NCT03134833; https://clinicaltrials.gov/ct2/show/NCT03134833 (Archived by WebCite at http://www.webcitation.org/76el0Viw9). DERR1-10.2196/11165.

Sections du résumé

BACKGROUND
America's increasing HIV epidemic among youth suggests the need to identify novel strategies to leverage services and settings where youth at high risk (YAHR) for HIV can be engaged in prevention. Scalable, efficacious, and cost-effective strategies are needed, which support youth during developmental transitions when risks arise. Evidence-based behavioral interventions (EBIs) have typically relied on time-limited, scripted, and manualized protocols that were often delivered with low fidelity and lacked evidence for effectiveness.
OBJECTIVE
This study aims to examine efficacy, implementation, and cost-effectiveness of easily mountable and adaptable, technology-based behavioral interventions in the context of an enhanced standard of care and study assessments that implement the guidelines of Centers for Disease Control and Prevention (CDC) for routine, repeat HIV, and sexually transmitted infection (STI) testing for high-risk youth.
METHODS
Youth aged between 12 and 24 years (n=1500) are being recruited from community-based organizations and clinics serving gay, bisexual, and transgender youth, homeless youth, and postincarcerated youth, with eligibility algorithms weighting African American and Latino youth to reflect disparities in HIV incidence. At baseline and 4-month intervals over 24 months (12 months for lower-risk youth), interviewers monitor uptake of HIV prevention continuum steps (linkage to health care, use of pre- or postexposure prophylaxis, condoms, and prevention services) and secondary outcomes of substance use, mental health, and housing security. Assessments include rapid diagnostic tests for HIV, STIs, drugs, and alcohol. The study is powered to detect modest intervention effects among gay or bisexual male and transgender youth with 70% retention. Youth are randomized to 4 conditions: (1) enhanced standard of care of automated text-messaging and monitoring (AMM) and repeat HIV/STI testing assessment procedures (n=690); (2) online group peer support via private social media plus AMM (n=270); (3) coaching that is strengths-based, youth-centered, unscripted, based on common practice elements of EBI, available over 24 months, and delivered by near-peer paraprofessionals via text, phone, and in-person, plus AMM (n=270); and (4) online group peer support plus coaching and AMM (n=270).
RESULTS
The project was funded in September 2016 and enrollment began in May 2017. Enrollment will be completed between June and August 2019. Data analysis is currently underway, and the first results are expected to be submitted for publication in 2019.
CONCLUSIONS
This hybrid implementation-effectiveness study examines alternative models for implementing the CDC guidelines for routine HIV/STI testing for YAHR of acquiring HIV and for delivering evidence-based behavioral intervention content in modular elements instead of scripted manuals and available over 24 months of follow-up, while also monitoring implementation, costs, and effectiveness. The greatest impacts are expected for coaching, whereas online group peer support is expected to have lower impact but may be more cost-effective.
TRIAL REGISTRATION
ClinicalTrials.gov NCT03134833; https://clinicaltrials.gov/ct2/show/NCT03134833 (Archived by WebCite at http://www.webcitation.org/76el0Viw9).
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)
DERR1-10.2196/11165.

Identifiants

pubmed: 31400109
pii: v8i8e11165
doi: 10.2196/11165
pmc: PMC6707028
doi:

Banques de données

ClinicalTrials.gov
['NCT03134833']

Types de publication

Journal Article

Langues

eng

Pagination

e11165

Subventions

Organisme : NIAID NIH HHS
ID : P30 AI028697
Pays : United States
Organisme : NIMH NIH HHS
ID : P30 MH058107
Pays : United States
Organisme : NICHD NIH HHS
ID : U19 HD089886
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000124
Pays : United States

Investigateurs

Mary Jane Rotheram-Borus (MJ)
Sue Ellen Abdalian (SE)
M Isabel Fernandez (MI)
Jeffrey D Klausner (JD)
Sung-Jae Lee (SJ)
Maryann Koussa (M)
Leslie Kozina (L)
Manuel Ocasio (M)
W Scott Comulada (WS)
Robert E Weiss (RE)
Ronald Brookmeyer (R)
Wenze Tang (W)
Karin Nielson (K)
Yvonne Bryson (Y)
Tara Kerin (T)
Chelsea Shannon (C)
Ruth Cortado (R)
Kate Mitchell (K)
Elizabeth Mayfield Arnold (E)
Norweeta Milburn (N)
Dallas Swendeman (D)
Cathy Reback (C)
Marguerita Lightfoot (M)
Danielle Harris (D)
Jasmine Fournier (J)

Informations de copyright

©Dallas Swendeman, Elizabeth Mayfield Arnold, Danielle Harris, Jasmine Fournier, W Scott Comulada, Cathy Reback, Maryann Koussa, Manuel Ocasio, Sung-Jae Lee, Leslie Kozina, Maria Isabel Fernández, Mary Jane Rotheram, Adolescent Medicine Trials Network (ATN) CARES Team. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 09.08.2019.

Références

AIDS Care. 2007 Jul;19(6):757-63
pubmed: 17573595
JMIR Res Protoc. 2018 Dec 14;7(12):e10777
pubmed: 30552083
Am J Drug Alcohol Abuse. 2009;35(1):43-7
pubmed: 19152206
AIDS Care. 2012;24(12):1461-9
pubmed: 22428809
Am J Psychiatry. 2002 Dec;159(12):2062-8
pubmed: 12450957
AIDS Behav. 2003 Jun;7(2):119-29
pubmed: 14586197
BMC Public Health. 2014 Nov 26;14:1226
pubmed: 25427749
J Infect Dis. 2001 Mar 1;183(5):707-14
pubmed: 11181146
J Youth Adolesc. 2012 May;41(5):544-60
pubmed: 21656284
Addiction. 2013 Jul;108(7):1230-40
pubmed: 23432593
Psychiatr Serv. 2012 Jul;63(7):708-10
pubmed: 22752035
Open AIDS J. 2010 May 14;4:116-22
pubmed: 20657827
J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):597-606
pubmed: 18285714
J Adolesc. 1998 Jun;21(3):241-52
pubmed: 9657892
AIDS Behav. 2012 Feb;16(2):432-40
pubmed: 21311964
J Comput Mediat Commun. 2014 Jan 1;19(2):232-247
pubmed: 25328374
JMIR Mhealth Uhealth. 2018 Sep 21;6(9):e176
pubmed: 30249576
J Med Internet Res. 2013 Jan 04;15(1):e1
pubmed: 23291245
Lancet. 2012 Apr 28;379(9826):1641-52
pubmed: 22538179
AIDS Care. 2009 Oct;21(10):1321-34
pubmed: 20024709
Med Care. 1996 Dec;34(12 Suppl):DS197-9
pubmed: 8969326
J Adolesc Health. 2012 Sep;51(3):207-12
pubmed: 22921129
Addict Behav. 2010 May;35(5):464-70
pubmed: 20092953
Am Psychol. 2012 Sep;67(6):463-76
pubmed: 22545596
Future Child. 1998 Summer-Fall;8(2):39-59
pubmed: 9782649
Trials. 2017 Aug 10;18(1):374
pubmed: 28797307
J Adolesc Health. 2018 Apr;62(4):424-433
pubmed: 29224988
AIDS Behav. 2013 Nov;17(9):3024-33
pubmed: 23180156
Annu Rev Psychol. 2001;52:1-26
pubmed: 11148297
PLoS Med. 2013;10(2):e1001382
pubmed: 23424286
AIDS Behav. 2016 Jun;20(6):1157-72
pubmed: 26238038
Am J Public Health. 1991 May;81 Suppl:50-3
pubmed: 2014885
AIDS Behav. 2008 May;12(3):374-83
pubmed: 18330687
Health Psychol. 2006 Jul;25(4):501-9
pubmed: 16846325
AIDS Behav. 2014 Aug;18(8):1501-10
pubmed: 24682848
JMIR Res Protoc. 2019 Jan 21;8(1):e10759
pubmed: 30664482
J Clin Child Adolesc Psychol. 2014;43(2):229-43
pubmed: 24079747
Annu Rev Psychol. 1996;47:113-42
pubmed: 8624135
AIDS Behav. 2009 Jun;13(3):387-98
pubmed: 19224358
BMC Public Health. 2013 Apr 18;13:359
pubmed: 23594410
J Subst Abuse Treat. 2004 Mar;26(2):109-16
pubmed: 15050088
AIDS Behav. 2015 Feb;19(2):330-40
pubmed: 25331266
J Acquir Immune Defic Syndr. 2013 Jun 1;63 Suppl 1:S102-7
pubmed: 23673879
AIDS Behav. 2015 Jun;19 Suppl 2:130-41
pubmed: 25563501
Arch Pediatr Adolesc Med. 2011 Jun;165(6):547-53
pubmed: 21646588
J Int Assoc Provid AIDS Care. 2015 Nov-Dec;14 Suppl 1:S3-S34
pubmed: 26527218
JMIR Mhealth Uhealth. 2017 Apr 13;5(4):e46
pubmed: 28408360
JAMA. 1999 Dec 15;282(23):2227-34
pubmed: 10605974
Curr HIV/AIDS Rep. 2015 Dec;12(4):481-8
pubmed: 26519083
Curr HIV/AIDS Rep. 2015 Mar;12(1):173-90
pubmed: 25626718
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
AIDS Behav. 2009 Jun;13(3):399-408
pubmed: 18830813
Health Educ Behav. 2011 Jun;38(3):311-20
pubmed: 21393625
J Adolesc Health. 2001 Sep;29(3 Suppl):72-9
pubmed: 11530306
Curr Opin HIV AIDS. 2013 Jan;8(1):50-8
pubmed: 23201856
AIDS Behav. 2019 Jan;23(1):37-47
pubmed: 30006792
JMIR Mhealth Uhealth. 2015 Dec 18;3(4):e106
pubmed: 26685288
J Subst Abuse Treat. 2008 Jan;34(1):25-35
pubmed: 17574798
Lancet HIV. 2015 Jan;2(1):e27-32
pubmed: 26236767
Paediatr Child Health. 2008 Sep;13(7):619-30
pubmed: 19436504
J Pediatr. 2014 Mar;164(3):625-30
pubmed: 24286572
MMWR Recomm Rep. 2006 Sep 22;55(RR-14):1-17; quiz CE1-4
pubmed: 16988643
J Consult Clin Psychol. 2009 Jun;77(3):566-79
pubmed: 19485596
Curr HIV/AIDS Rep. 2015 Dec;12(4):500-15
pubmed: 26385582
Suicide Life Threat Behav. 1995;25 Suppl:26-34; discussion 35-9
pubmed: 8553426
Clin Infect Dis. 2007 Dec 15;45 Suppl 4:S248-54
pubmed: 18190295
Prev Sci. 2011 Dec;12(4):372-88
pubmed: 21850488
Ann Fam Med. 2010 Nov-Dec;8(6):511-6
pubmed: 21060121
Arch Womens Ment Health. 2014 Oct;17(5):423-31
pubmed: 24682529
Curr HIV/AIDS Rep. 2007 Dec;4(4):173-80
pubmed: 18366948
J Adolesc Health. 2010 Dec;47(6):610-3
pubmed: 21094441
J Med Internet Res. 2009 May 14;11(2):e16
pubmed: 19632970
Am J Community Psychol. 1998 Apr;26(2):281-306
pubmed: 9693693
AIDS. 2013 Jun 1;27(9):1461-71
pubmed: 23435303
Annu Rev Clin Psychol. 2009;5:143-67
pubmed: 19327028
J Stud Alcohol Drugs. 2008 Jan;69(1):58-64
pubmed: 18080065
J Sex Res. 2015;52(2):220-30
pubmed: 24588408
JAMA Pediatr. 2018 Dec 1;172(12):1117-1118
pubmed: 30326015
JMIR Res Protoc. 2019 Feb 27;8(2):e10791
pubmed: 30810536
BMJ. 2004 May 15;328(7449):1166
pubmed: 15142921
Arch Sex Behav. 2015 Feb;44(2):475-85
pubmed: 25135064
Health Educ Q. 1984 Spring;11(1):1-47
pubmed: 6392204
Drug Alcohol Depend. 2005 Aug 1;79(2):241-50
pubmed: 16002033
Psychol Addict Behav. 2010 Mar;24(1):109-118
pubmed: 20307117
Clin Infect Dis. 2014 Jul;59 Suppl 1:S12-5
pubmed: 24926026
Comput Biol Med. 1998 Sep;28(5):489-508
pubmed: 9861507
Prev Chronic Dis. 2013;10:E26
pubmed: 23428085
AIDS Behav. 2011 Apr;15 Suppl 1:S91-100
pubmed: 21360127
AIDS Behav. 2012 Oct;16(7):1993-2002
pubmed: 22610370
Fam Pract. 2010 Jun;27 Suppl 1:i62-8
pubmed: 20483801
Curr Opin Psychiatry. 2010 Mar;23(2):139-44
pubmed: 20087189
J Acquir Immune Defic Syndr. 2015 May 1;69 Suppl 1:S80-91
pubmed: 25867783
Vulnerable Child Youth Stud. 2009 Jan 1;4(4):346-352
pubmed: 21494426
J Med Internet Res. 2012 Apr 05;14(2):e51
pubmed: 22481246
JMIR Res Protoc. 2019 Jan 16;8(1):e10807
pubmed: 30650057
Int J Med Inform. 2013 Apr;82(4):e38-46
pubmed: 22704234

Auteurs

Dallas Swendeman (D)

University of California, Los Angeles, Department of Psychiatry & Biobehavioral Sciences, Los Angeles, CA, United States.

Elizabeth Mayfield Arnold (EM)

Department of Family and Community Medicine, UT Southwestern Medical Center, Dallas, TX, United States.

Danielle Harris (D)

University of California, Los Angeles, Department of Psychiatry & Biobehavioral Sciences, Los Angeles, CA, United States.

Jasmine Fournier (J)

Tulane University School of Medicine, Department of Pediatrics, New Orleans, LA, United States.

W Scott Comulada (WS)

University of California, Los Angeles, Department of Psychiatry & Biobehavioral Sciences, Los Angeles, CA, United States.

Cathy Reback (C)

University of California, Los Angeles, Department of Psychiatry & Biobehavioral Sciences, Los Angeles, CA, United States.

Maryann Koussa (M)

University of California, Los Angeles, Department of Psychiatry & Biobehavioral Sciences, Los Angeles, CA, United States.

Manuel Ocasio (M)

Tulane University School of Medicine, Department of Pediatrics, New Orleans, LA, United States.

Sung-Jae Lee (SJ)

University of California, Los Angeles, Department of Psychiatry & Biobehavioral Sciences, Los Angeles, CA, United States.

Leslie Kozina (L)

Tulane University School of Medicine, Department of Pediatrics, New Orleans, LA, United States.

Maria Isabel Fernández (MI)

Nova Southeastern University, College of Osteopathic Medicine, Fort Lauderdale, FL, United States.

Mary Jane Rotheram (MJ)

University of California, Los Angeles, Department of Psychiatry & Biobehavioral Sciences, Los Angeles, CA, United States.
University of California, Los Angeles, Department of Psychiatry & Biobehavioral Sciences, Los Angeles, CA, United States.
Department of Family and Community Medicine, UT Southwestern Medical Center, Dallas, TX, United States.
Tulane University School of Medicine, Department of Pediatrics, New Orleans, LA, United States.
Nova Southeastern University, College of Osteopathic Medicine, Fort Lauderdale, FL, United States.

Classifications MeSH